...
首页> 外文期刊>European Journal of Nuclear Medicine and Molecular Imaging >Nuclear cardiology at the door of a new era: better to save mSv or to reduce imaging time?
【24h】

Nuclear cardiology at the door of a new era: better to save mSv or to reduce imaging time?

机译:新时代之门的核心内科:更好地保存mSv或减少成像时间?

获取原文
获取原文并翻译 | 示例

摘要

The evolution of nuclear cardiology has gone through several clinical protocols that can be summarized as ~(201)Tl stress/redistribution,~(201)IT1 stress/redistribution with delayed imaging, ~(201)Tl stress/redistribution with reinjection, single-or double-day ~(99m)Tc-labelled radiotracers, and ~(201)Tl/~(99m)Tc combined approaches. This evolution covered more or less 30 years with a significant (at least 25 %) increase in the accuracy of the method, but (up to few years ago) a decrease in the mSv to the patient of less than 5 %. Recent advances in hardware and software applied to nuclear cardiology [1] have led to short imaging times and/or low-dose studies, but the choice of the best combination is still difficult.
机译:核心脏病学的发展经历了几种临床方案,可以概括为〜(201)T1应力/重新分布,延迟成像,〜(201)T1应力/重新分布,延迟成像,〜(201)T1应力/重新注入,单次或双天〜(99m)Tc标记的放射性示踪剂,以及〜(201)Tl /〜(99m)Tc组合方法。这种演变历时约30年,其方法的准确性显着提高(至少25%),但直到几年前,患者的mSv下降不到5%。应用于核心脏病学的硬件和软件的最新进展[1]缩短了成像时间和/或进行了低剂量研究,但是最佳组合的选择仍然很困难。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号